Skip to main content
Skip to footer
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Home
Triverity
Education
Acute infection & sepsis
Immune Response
Machine Learning
Advocacy
Evidence
Publications
Abstracts
Pipeline
News
News
Press Release
ML Blogs
Podcasts
Media contact
Careers
About
Leadership
Investors
Partner with us
Awards
Certificates
Reach out
Reach out
Author:
Pedro Colmenarez
Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics
January 10, 2020
Inflammatix Raises $32M in Series C Financing
January 10, 2020
Genetic platform takes the guesswork out of catching infections
December 4, 2019
BARDA awards contract to Inflammatix for innovative diagnostic test systems
November 18, 2019
BARDA backs Inflammatix test to improve antibiotic use
November 15, 2019
Inflammatix Nabs $6M from BARDA to Develop POC Acute Infection Diagnostic
November 15, 2019
Inflammatix Announces Funding from BARDA to Advance HostDx™ Tests
November 14, 2019
Burlingame, Calif., November 14, 2019 — HostDx Fever Test Reads the Immune System to Rapidly Diagnose Acute Infections at Point of Care. Inflammatix,…
Inflammatix scores BARDA contract for infection tests
November 14, 2019
How $6 million could help a small Peninsula company spot deadly infections
November 14, 2019
Inflammatix Inks BARDA Contract for up to $72M
November 14, 2019
←
1
…
5
6
7
8
9
10
→